Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Distribution Deals United States

Perrigo Plays To OTC Strength With GoodSense Firm Acquisition

  • News

Executive Summary

Geiss, Destin & Dunn's GoodSense brand includes more than 1,500 OTC drugs and nutritional products. The deal could help diminish the impact of earnings headwinds on Perrigo's branded consumer health and Rx generic topicals businesses.

You may also be interested in...



Private Label Magnesium Citrate Laxative Solutions Recalled

Widespread recall of private label magnesium citrate laxative solution made by Vi-Jon; and potential bacteria contamination prompts Inopak antibacterial soap recall.

Private Label Magnesium Citrate Laxative Solutions Recalled

Widespread recall of private label magnesium citrate laxative solution made by Vi-Jon; and potential bacteria contamination prompts Inopak antibacterial soap recall.

Perrigo Changes Reporting Structure In Latest Stop On Cost-Cutting Trail

Perrigo reorganizes its reporting segments to better align with its organizational structure; consumer product units are combined and renamed.

Table

View full table

Related Content

HBW Insight
Pink Sheet

Topics

Related Companies

Tags:
Distribution Deals United States
Latest Headlines

US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios

FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Kahn Says

New EU Filings

WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency

See All
UsernamePublicRestriction

Register

PS118980

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By